Joint Formulary & PAD

Formoterol (Easyhaler Formoterol) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Formoterol (Easyhaler Formoterol)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LABA
Keywords :
LABAs, adrenoreceptor agonists, bronchodilators, long acting beta 2 agonist, respiratory
Brand Names Include :
Easyhaler Formoterol
Important Information :

Easyhaler Formoterol

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3

Other Indications

Below are listed other indications that Formoterol (Easyhaler Formoterol) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (0)

  • No records returned.